Tempus AI Investor Relations Material

Tempus AI Inc. is a technology company that focuses on advancing precision medicine through the use of artificial intelligence, including generative AI. The company offers a suite of products aimed at improving patient care by enabling physicians to make data-driven decisions in near real-time. Tempus leverages one of the world's largest libraries of clinical and molecular data, combined with an operating system that makes this data accessible and actionable. Its tools and platforms support the discovery, development, and delivery of personalized treatments by providing insights that are continuously enhanced as more data is gathered. The company is headquartered in Chicago, Illinois, and its shares are listed on the NASDAQ.